Technovax Inc.

UEI
CQC1WKNLJC41
CAGE
4HCV5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Hispanic American Owned
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
technovax.com
Founded
2003
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Army 15.1 sbir topic DHA funded sbir 2ND phase II medical r & d contract for proposal #H2-0475, titled… W81XWH19C0169 Medical Command (Army) $2,574,853
Phase II award H2-6324 W81XWH16C0113 Medical Command (Army) $1,999,176
Army phase one sbir proposal# A151-051-0493 W81XWH15C0178 Medical Command (Army) $150,000
Purchase of virus-like particles HHSD2002011M38169P CDC Office of Acquisition Services $5,100

Grant awards

Award Agency Obligated Awarded
Production and testing of VLP-based RSV vaccine R43AI145499 National Institute of Allergy and Infectious Diseases (NIH) $300,000
Development, production and testing of VLP based respiratory syncytial virus (RSV R43AI108099 National Institutes of Health $509,623
Universal VLP-based flu vaccine:broadly protective (universal) virus-like particle (VLP) based influenza vaccine that… R44AI106145 National Institute of Allergy and Infectious Diseases (NIH) $1,481,143
Broadly protective (universal) virus-like particle (VLP) based influenza vaccine R43AI106145 National Institutes of Health $600,000
Development of influenza virus-like particle (VLP) vaccines R44AI063830 National Institutes of Health $2,947,514

Quick answers

Is Technovax Inc. registered in SAM.gov?

Technovax Inc.'s SAM.gov registration expired on January 9, 2025.

What is Technovax Inc.'s most recent federal award?

Technovax Inc.'s most recent federal grant award is Production and testing of VLP-based RSV vaccine (R43AI145499), from National Institute of Allergy and Infectious Diseases (NIH), on August 3, 2020.

On GovTribe

See Technovax Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login